Norimichi Nemoto
Papers
1
Total Citations
12
H-Index
1
About
Norimichi Nemoto is a leading figure in molecular pathology, with a career dedicated to refining the diagnostic precision of breast cancer biomarkers. His key research areas center on the molecular characterization of solid tumors, particularly the correlation between protein expression and gene amplification. Nemoto’s most impactful work introduced a groundbreaking methodological approach, utilizing laser-assisted microdissection to isolate pure tumor cell populations. This technique allowed for a definitive comparison of HER2 mRNA amplification with standard immunohistochemistry in breast cancer, directly addressing the critical need for accurate patient stratification for trastuzumab therapy. His seminal 2004 study, which has garnered significant attention, demonstrated the power of this precise molecular analysis to validate and potentially improve upon traditional protein-based scoring systems. By bridging the gap between histopathology and molecular biology, Nemoto’s contributions have provided a more reliable framework for identifying patients who will benefit from targeted therapies, solidifying his reputation as a meticulous innovator in translational cancer research.
Research Focus
Key Achievements
Top Papers
- 1